Copyright
©The Author(s) 2022.
World J Clin Cases. Feb 6, 2022; 10(4): 1164-1171
Published online Feb 6, 2022. doi: 10.12998/wjcc.v10.i4.1164
Published online Feb 6, 2022. doi: 10.12998/wjcc.v10.i4.1164
Table 1 General information on 45 patients with advanced non-small cell lung cancer
| Features | Basic information |
| Age | 65 yr (35-83 yr) |
| Gender | |
| Male | 27 |
| Female | 18 |
| Pathological type | |
| Squamous cell carcinoma | 10 |
| Adenocarcinoma | 35 |
| Chemotherapy regimen | |
| AP | 13 |
| GP | 5 |
| Pemetrexed monotherapy | 16 |
| Docetaxel monotherapy | 11 |
- Citation: Qin ZQ, Yang SF, Chen Y, Hong CJ, Zhao TW, Yuan GR, Yang L, Gao L, Wang X, Lu LQ. Continuous intravenous infusion of recombinant human endostatin using infusion pump plus chemotherapy in non-small cell lung cancer. World J Clin Cases 2022; 10(4): 1164-1171
- URL: https://www.wjgnet.com/2307-8960/full/v10/i4/1164.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i4.1164